Clinical Significance of Soluble Programmed Cell Death Ligand-1 (sPD-L1) in Hepatocellular Carcinoma Patients Treated with RadiotherapyOct 1, 2018·Hyun Ju Kim,Sangjoon Park,Kyoung-Jin Kim,Jinsil Seong✉· 0 min read PDF CitePublicationRadiotherapy and Oncology, 129(1), 130-135Last updated on Mar 8, 2025 ← Risk Group-Adapted Adjuvant Radiotherapy for WHO Grade I and II Skull Base Meningioma Apr 5, 2019Compensatory Hypertrophy of the Liver After External Beam Radiotherapy for Primary Liver Cancer Aug 13, 2018 →